ArticleMolecular cancer therapeutics2026

A Novel Dual-Payload ADC Platform Integrating Exatecan and Triptolide to Enhance Antitumor Efficacy and Overcome Resistance.

Pengfei Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.